The Historic Orphan Drug Act
Dottie Ballmann2024-11-10T15:48:29-05:00Before 1983, if you were one of approximately 30 million people in the United States who suffer from 10,000 “rare” diseases, you had no hope. Biotechnology and pharmaceutical companies did not invest in developing drugs and biologics for rare conditions because there was no reasonable expectation that the drug sales would recover the development costs.
The Orphan Drug Act of 1983 is a U.S. law designed to encourage the development of treatments for […]